Evogene EVGN
Evogene targets aGVHD in AI drug program
Foreign issuer report
- Form
- 6-K
- Filed
- Importance
- Routine
- Accession
- 0001178913-26-004871
- Announced aGVHD as target indication
- Incorporated by reference in multiple registration statements
Written from the 6-K on EDGAR. Check the filing before you rely on it.
Similar companies
Companies of similar size in SIC 2870 and related industry codes: the same peer list as the financial tables.
- American Vanguard AVD public float $111M, Jun 30, 2025
- Bioceres Crop Solutions BIOX
- Bion Environmental Technologies BNET public float $9M, Jun 30, 2026
- Cibus CBUS public float $47M, Jun 30, 2025
- CF Industries Holdings CF public float $14.8B, Jun 30, 2025